Zhitong Finance App learned that on July 24, the China Securities Regulatory Commission announced the requirements for supplementary materials for overseas issuance and listing registration (July 13, 2026 to July 24, 2026). The Securities Regulatory Commission requested Qualtipo Biotech to further explain whether there is a correlation between shareholders holding less than 5% of the shares. If so, whether the shareholding ratio should be calculated collectively, and those over 5% should be thoroughly verified by shareholders of 5% or more. According to the Hong Kong Stock Exchange's disclosure on April 24, Peptide Biotech submitted a listing application to the Hong Kong Stock Exchange. The co-sponsors are Jefferies and Huatai International.

Zhitong Finance App learned that on July 24, the China Securities Regulatory Commission announced the requirements for supplementary materials for overseas issuance and listing registration (July 13, 2026 to July 24, 2026). The Securities Regulatory Commission requested Qualtipo Biotech to further explain whether there is a correlation between shareholders holding less than 5% of the shares. If so, whether the shareholding ratio should be calculated collectively, and those over 5% should be thoroughly verified by shareholders of 5% or more. According to the Hong Kong Stock Exchange's disclosure on April 24, Peptide Biotech submitted a listing application to the Hong Kong Stock Exchange. The co-sponsors are Jefferies and Huatai International.